Acco Group Holdings Limited (ACCL) vs BioHarvest Sciences Inc. (BHST)

A side-by-side comparison of Acco Group Holdings Limited and BioHarvest Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACCL vs BHST

growth of $100 · dividends reinvested · last 1y
ACCL -36.3% (-36.3%/yr)BHST -86.7% (-86.7%/yr)ACCL compounded faster over this window
20406080100Start $1002026$64$13
ACCL BHST

ACCL vs BHST: by the numbers

  • •ACCL is the larger company ($36M vs $25M market cap).
  • •ACCL is profitable (20.90% net margin) while BHST runs a net loss (-31.21%).

Metrics side by side

Valuation

MetricACCLBHST
P/S ratioN/A0.72
P/B ratio48.411.28

Profitability

MetricACCLBHST
Gross margin43.77%58.95%
Operating margin22.09%-17.99%
Net margin20.90%-31.21%
ROE464.53%-56.03%
ROIC25.45%-17.10%

Growth (annualized)

MetricACCLBHST
Revenue CAGR (5Y)N/A102.48%

Frequently asked

Is ACCL or BHST more profitable?
ACCL runs the higher net margin — ACCL at 20.90% versus BHST at -31.21%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.